BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15951302)

  • 21. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
    Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
    Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
    Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
    Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
    Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
    Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
    Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
    Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
    Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
    Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
    Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
    Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
    Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
    Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
    Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
    Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
    Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
    Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
    Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
    Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
    Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
    Gautschi O; Ratschiller D; Gugger M; Betticher DC; Heighway J
    Lung Cancer; 2007 Jan; 55(1):1-14. PubMed ID: 17070615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
    Masamha CP; Albrecht TR; Wagner EJ
    J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
    Balcerczak E; Pasz-Walczak G; Kumor P; Panczyk M; Kordek R; Wierzbicki R; Mirowski M
    Eur J Surg Oncol; 2005 Sep; 31(7):721-6. PubMed ID: 15993030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
    Wickham CL; Armitage H; Joyner MV; Sarsfield P; Boyce M; Wilkins BS; Jones DB; Ellard S
    Med Oncol; 2003; 20(1):77-85. PubMed ID: 12665688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
    Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
    Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.